IA
FOMX

IFP Advisors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

IFP Advisors’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200
Closed -$1K – 4245
2017
Q3 		$1K Hold
200
– – ﹤0.01% 4006
2017
Q2 		$1K Hold
200
– – ﹤0.01% 4002
2017
Q1 		$1K Hold
200
– – ﹤0.01% 3905
2016
Q4 		$2K Hold
200
– – ﹤0.01% 3707
2016
Q3 		$2K Hold
200
– – ﹤0.01% 3654
2016
Q2 		$1K Buy
+200
New +$1.33K ﹤0.01% 3733
2016
Q1 		– Sell
-200
Closed -$2K – 3778
2015
Q4 		$2K Buy
+200
New +$1.5K ﹤0.01% 3412

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IFP Advisors's FOMX Position: Q4 2017 in Review

IFP Advisors sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2017, closing a stake of 200 shares — an estimated $1K sold.

IFP Advisors first reported a position in FOMX in Q4 2015 and held it in 7 quarters. The position peaked at $2K in Q4 2016. 48 funds tracked by Wall St. Rank hold FOMX as of Q4 2017.

  • IFP Advisors reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • IFP Advisors sold 200 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2017, an estimated $1K.
  • IFP Advisors first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2015 and held it in 7 quarters.
  • IFP Advisors's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $2K in Q4 2016.
  • 48 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2017.

Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.